Communication Equipment
Compare Stocks
5 / 10Stock Comparison
MITQ vs MVIS vs VUZI vs NCMI vs IMAX
Revenue, margins, valuation, and 5-year total return — side by side.
Hardware, Equipment & Parts
Consumer Electronics
Advertising Agencies
Entertainment
MITQ vs MVIS vs VUZI vs NCMI vs IMAX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Communication Equipment | Hardware, Equipment & Parts | Consumer Electronics | Advertising Agencies | Entertainment |
| Market Cap | $6M | $189M | $232M | $346M | $1.92B |
| Revenue (TTM) | $19M | $1M | $5M | $243M | $405M |
| Net Income (TTM) | $-275K | $-95M | $-32.28B | $-11M | $43M |
| Gross Margin | 27.1% | -14.4% | -0.0% | 30.3% | 58.1% |
| Operating Margin | -2.7% | -57.4% | -5.2% | -5.7% | 21.4% |
| Forward P/E | — | — | — | — | 21.1x |
| Total Debt | $1M | $37M | $1.00B | $23M | $297M |
| Cash & Equiv. | $6M | $32M | $21.15B | $75M | $151M |
MITQ vs MVIS vs VUZI vs NCMI vs IMAX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 21 | May 26 | Return |
|---|---|---|---|
| Moving iMage Techno… (MITQ) | 100 | 16.0 | -84.0% |
| MicroVision, Inc. (MVIS) | 100 | 4.5 | -95.5% |
| Vuzix Corporation (VUZI) | 100 | 19.3 | -80.7% |
| National CineMedia,… (NCMI) | 100 | 10.7 | -89.3% |
| IMAX Corporation (IMAX) | 100 | 220.8 | +120.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MITQ vs MVIS vs VUZI vs NCMI vs IMAX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MITQ ranks third and is worth considering specifically for sleep-well-at-night.
- Lower volatility, beta 0.74, Low D/E 23.6%, current ratio 1.84x
- Better valuation composite
MVIS lags the leaders in this set but could rank higher in a more targeted comparison.
VUZI carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 3 yrs, beta 3.40, yield 10.1%
- Rev growth 1.1K%, EPS growth 61.1%, 3Y rev CAGR 7.1%
- Beta 3.40, yield 10.1%, current ratio 5.56x
- 1.1K% revenue growth vs MVIS's -74.3%
Among these 5 stocks, NCMI doesn't own a clear edge in any measured category.
IMAX is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 8.9% 10Y total return vs VUZI's -35.7%
- 10.7% margin vs MVIS's -78.6%
- Beta 0.43 vs VUZI's 3.40
- 4.9% ROA vs VUZI's -321.3%, ROIC 12.7% vs -10.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 1.1K% revenue growth vs MVIS's -74.3% | |
| Value | Better valuation composite | |
| Quality / Margins | 10.7% margin vs MVIS's -78.6% | |
| Stability / Safety | Beta 0.43 vs VUZI's 3.40 | |
| Dividends | 10.1% yield, 3-year raise streak, vs NCMI's 3.3%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +63.4% vs MVIS's -45.5% | |
| Efficiency (ROA) | 4.9% ROA vs VUZI's -321.3%, ROIC 12.7% vs -10.7% |
MITQ vs MVIS vs VUZI vs NCMI vs IMAX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
MITQ vs MVIS vs VUZI vs NCMI vs IMAX — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
IMAX leads in 4 of 6 categories
VUZI leads 1 • MITQ leads 0 • MVIS leads 0 • NCMI leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
IMAX leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
IMAX is the larger business by revenue, generating $405M annually — 335.2x MVIS's $1M. IMAX is the more profitable business, keeping 10.7% of every revenue dollar as net income compared to MVIS's -78.6%. On growth, VUZI holds the edge at +4933.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $19M | $1M | $5M | $243M | $405M |
| EBITDAEarnings before interest/tax | -$358,000 | -$64M | -$30.9B | $24M | $150M |
| Net IncomeAfter-tax profit | -$275,000 | -$95M | -$32.3B | -$11M | $43M |
| Free Cash FlowCash after capex | -$1M | -$59M | -$20.8B | $4M | $115M |
| Gross MarginGross profit ÷ Revenue | +27.1% | -14.4% | -0.0% | +30.3% | +58.1% |
| Operating MarginEBIT ÷ Revenue | -2.7% | -57.4% | -5.2% | -5.7% | +21.4% |
| Net MarginNet income ÷ Revenue | -1.5% | -78.6% | -5.1% | -4.4% | +10.7% |
| FCF MarginFCF ÷ Revenue | -7.5% | -49.2% | -3.3% | +1.8% | +28.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +10.2% | -86.5% | +4933.1% | +7.9% | -6.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +24.8% | +14.3% | +25.0% | +24.0% | +65.5% |
Valuation Metrics
Evenly matched — VUZI and NCMI each lead in 2 of 5 comparable metrics.
Valuation Metrics
On an enterprise value basis, NCMI's 12.2x EV/EBITDA is more attractive than IMAX's 13.1x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $6M | $189M | $232M | $346M | $1.9B |
| Enterprise ValueMkt cap + debt − cash | $2M | $193M | -$19.9B | $293M | $2.1B |
| Trailing P/EPrice ÷ TTM EPS | -6.48x | -1.76x | -6.81x | -33.73x | 56.56x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | — | 21.15x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | — | — | 12.23x | 13.10x |
| Price / SalesMarket cap ÷ Revenue | 0.34x | 156.30x | 0.04x | 1.42x | 4.69x |
| Price / BookPrice ÷ Book value/share | 1.26x | 3.03x | 0.01x | 0.85x | 4.63x |
| Price / FCFMarket cap ÷ FCF | 14.11x | — | — | 123.60x | 16.18x |
Profitability & Efficiency
IMAX leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
IMAX delivers a 10.8% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-5 for VUZI. VUZI carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to IMAX's 0.70x. On the Piotroski fundamental quality scale (0–9), NCMI scores 7/9 vs VUZI's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -5.5% | -137.4% | -5.2% | -2.9% | +10.8% |
| ROA (TTM)Return on assets | -20.7% | -74.3% | -3.2% | -2.1% | +4.9% |
| ROICReturn on invested capital | -187.2% | -98.3% | -10.7% | -2.9% | +12.7% |
| ROCEReturn on capital employed | -18.9% | -93.6% | -184.6% | -2.8% | +14.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 3 | 2 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.24x | 0.66x | 0.04x | 0.05x | 0.70x |
| Net DebtTotal debt minus cash | -$5M | $4M | -$20.1B | -$53M | $146M |
| Cash & Equiv.Liquid assets | $6M | $32M | $21.2B | $75M | $151M |
| Total DebtShort + long-term debt | $1M | $37M | $1.0B | $23M | $297M |
| Interest CoverageEBIT ÷ Interest expense | — | -3.54x | — | -23.17x | 21.15x |
Total Returns (Dividends Reinvested)
IMAX leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in IMAX five years ago would be worth $17,034 today (with dividends reinvested), compared to $258 for MITQ. Over the past 12 months, VUZI leads with a +63.4% total return vs MVIS's -45.5%. The 3-year compound annual growth rate (CAGR) favors IMAX at 21.5% vs MVIS's -35.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -7.2% | -30.8% | -25.7% | -2.6% | -1.1% |
| 1-Year ReturnPast 12 months | +12.7% | -45.5% | +63.4% | -25.3% | +38.9% |
| 3-Year ReturnCumulative with dividends | -35.4% | -73.6% | -29.6% | +26.6% | +79.5% |
| 5-Year ReturnCumulative with dividends | -97.4% | -95.6% | -84.8% | -85.3% | +70.3% |
| 10-Year ReturnCumulative with dividends | -97.4% | -66.2% | -35.7% | -71.0% | +8.9% |
| CAGR (3Y)Annualised 3-year return | -13.6% | -35.8% | -11.0% | +8.2% | +21.5% |
Risk & Volatility
IMAX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
IMAX is the less volatile stock with a 0.43 beta — it tends to amplify market swings less than VUZI's 3.40 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IMAX currently trades 82.6% from its 52-week high vs MVIS's 35.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.74x | 2.61x | 3.40x | 1.26x | 0.43x |
| 52-Week HighHighest price in past year | $1.66 | $1.73 | $4.29 | $5.56 | $43.16 |
| 52-Week LowLowest price in past year | $0.42 | $0.51 | $1.71 | $2.92 | $24.20 |
| % of 52W HighCurrent price vs 52-week peak | +37.3% | +35.6% | +66.7% | +66.7% | +82.6% |
| RSI (14)Momentum oscillator 0–100 | 52.1 | 50.3 | 61.1 | 58.3 | 42.4 |
| Avg Volume (50D)Average daily shares traded | 254K | 5.3M | 924K | 472K | 1.1M |
Analyst Outlook
VUZI leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: MVIS as "Buy", VUZI as "Buy", NCMI as "Hold", IMAX as "Buy". Consensus price targets imply 711.7% upside for MVIS (target: $5) vs 20.7% for IMAX (target: $43). For income investors, VUZI offers the higher dividend yield at 10.10% vs NCMI's 3.26%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | — | $5.00 | $6.00 | $7.50 | $43.00 |
| # AnalystsCovering analysts | — | 7 | 5 | 17 | 25 |
| Dividend YieldAnnual dividend ÷ price | — | — | +10.1% | +3.3% | — |
| Dividend StreakConsecutive years of raises | 0 | 0 | 3 | 1 | 1 |
| Dividend / ShareAnnual DPS | — | — | $0.29 | $0.12 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | +6.4% | +0.1% |
IMAX leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). VUZI leads in 1 (Analyst Outlook). 1 tied.
MITQ vs MVIS vs VUZI vs NCMI vs IMAX: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is MITQ or MVIS or VUZI or NCMI or IMAX a better buy right now?
For growth investors, Vuzix Corporation (VUZI) is the stronger pick with 1090% revenue growth year-over-year, versus -74.
3% for MicroVision, Inc. (MVIS). IMAX Corporation (IMAX) offers the better valuation at 56. 6x trailing P/E (21. 1x forward), making it the more compelling value choice. Analysts rate MicroVision, Inc. (MVIS) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — MITQ or MVIS or VUZI or NCMI or IMAX?
Over the past 5 years, IMAX Corporation (IMAX) delivered a total return of +70.
3%, compared to -97. 4% for Moving iMage Technologies, Inc. (MITQ). Over 10 years, the gap is even starker: IMAX returned +8. 9% versus MITQ's -97. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — MITQ or MVIS or VUZI or NCMI or IMAX?
By beta (market sensitivity over 5 years), IMAX Corporation (IMAX) is the lower-risk stock at 0.
43β versus Vuzix Corporation's 3. 40β — meaning VUZI is approximately 699% more volatile than IMAX relative to the S&P 500. On balance sheet safety, Vuzix Corporation (VUZI) carries a lower debt/equity ratio of 4% versus 70% for IMAX Corporation — giving it more financial flexibility in a downturn.
04Which is growing faster — MITQ or MVIS or VUZI or NCMI or IMAX?
By revenue growth (latest reported year), Vuzix Corporation (VUZI) is pulling ahead at 1090% versus -74.
3% for MicroVision, Inc. (MVIS). On earnings-per-share growth, the picture is similar: Vuzix Corporation grew EPS 61. 1% year-over-year, compared to 23. 9% for MicroVision, Inc.. Over a 3-year CAGR, VUZI leads at 709. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — MITQ or MVIS or VUZI or NCMI or IMAX?
IMAX Corporation (IMAX) is the more profitable company, earning 8.
5% net margin versus -78. 6% for MicroVision, Inc. — meaning it keeps 8. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IMAX leads at 23. 3% versus -57. 4% for MVIS. At the gross margin level — before operating expenses — IMAX leads at 57. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is MITQ or MVIS or VUZI or NCMI or IMAX more undervalued right now?
Analyst consensus price targets imply the most upside for MVIS: 711.
7% to $5. 00.
07Which pays a better dividend — MITQ or MVIS or VUZI or NCMI or IMAX?
In this comparison, VUZI (10.
1% yield), NCMI (3. 3% yield) pay a dividend. MITQ, MVIS, IMAX do not pay a meaningful dividend and should not be held primarily for income.
08Is MITQ or MVIS or VUZI or NCMI or IMAX better for a retirement portfolio?
For long-horizon retirement investors, IMAX Corporation (IMAX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
43)). MicroVision, Inc. (MVIS) carries a higher beta of 2. 61 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IMAX: +8. 9%, MVIS: -66. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between MITQ and MVIS and VUZI and NCMI and IMAX?
These companies operate in different sectors (MITQ (Technology) and MVIS (Technology) and VUZI (Technology) and NCMI (Communication Services) and IMAX (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: MITQ is a small-cap quality compounder stock; MVIS is a small-cap quality compounder stock; VUZI is a small-cap high-growth stock; NCMI is a small-cap income-oriented stock; IMAX is a small-cap high-growth stock. VUZI, NCMI pay a dividend while MITQ, MVIS, IMAX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Communication Services
- Market Cap > $100B
- Revenue Growth > 5%
- Gross Margin > 18%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.